David A. Siegel Soleno Therapeutics Inc Transaction History

Two Sigma Advisers, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.14 - $0.23 $2,016 - $3,312	-14,400 Reduced 5.84%	232,000 $43,000
Q1 2022 May 16, 2022	SELL	$0.22 - $0.47 $33,352 - $71,252	-151,600 Reduced 38.09%	246,400 $55,000
Q4 2021 Feb 14, 2022	SELL	$0.41 - $0.91 $141,860 - $314,860	-346,000 Reduced 46.51%	398,000 $163,000
Q3 2021 Nov 15, 2021	BUY	$0.8 - $1.12 $271,920 - $380,688	339,900 Added 84.11%	744,000 $688,000
Q2 2021 Aug 16, 2021	SELL	$0.97 - $1.32 $34,532 - $46,992	-35,600 Reduced 8.1%	404,100 $461,000
Q1 2021 May 17, 2021	SELL	$1.24 - $3.3 $49,476 - $131,670	-39,900 Reduced 8.32%	439,700 $554,000
Q4 2020 Feb 16, 2021	SELL	$1.61 - $2.23 $355,488 - $492,384	-220,800 Reduced 31.52%	479,600 $926,000
Q3 2020 Nov 16, 2020	BUY	$1.71 - $2.51 $1.17 Million - $1.72 Million	686,700 Added 5012.41%	700,400 $1.76 Million
Q2 2020 Aug 14, 2020	BUY	$1.77 - $4.23 $24,249 - $57,951	13,700 New	13,700 $30,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $375M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.